Bredin Prat is advising Sanofi on the French drugmaker’s buyback of close to 30 million of its own shares from cosmetics products giant L’Oréal, for €101.50 per share, or around €3 billion ($3.11 billion).

Bredin’s Paris-based team advising Sanofi included corporate partners Olivier Assant and Myriam Epelbaum and lawyer Armance Amadieu.